A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDD

Completed · Phase 3

Conditions studied: Major Depressive Disorder

In brief

This is a 6-month, open-label, flexible-dose study evaluating desvenlafaxine succinate sustained release (DVS SR) in the treatment of child and adolescent outpatients with major depressive disorder (MDD).

Key facts

Study ID

NCT01371721

Run by

Pfizer

People needed

269

Starts

2012-02-01

Expected to finish

2015-10-01

Last updated by the study team

2017-02-08

Who can join

Age: 7 and older, up to 17. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Completed study B2061014 and who in the investigator's opinion would benefit from long term treatment with DVS SR
• Willingness and ability to comply with scheduled visits, treatment plan and procedures

You may not qualify if…

• Subject requires precaution against suicide
• Subject not in a generally healthy condition

Where it is running

• Harmonex Neuroscience Research, Inc. — Dothan, Alabama, United States
• Dedicated Clinical Research — Goodyear, Arizona, United States
• University of Arizona Clinical and Translational Science Center (CATS) — Tucson, Arizona, United States
• University of Arizona College of Medicine Dept of Psychiatry — Tucson, Arizona, United States
• Arkansas Psychiatric Clinic Clinical Research Trials, P.A. — Little Rock, Arkansas, United States
• ATP Clinical Research, Incorporated — Costa Mesa, California, United States
• Behavioral Research Specialists, LLC — Glendale, California, United States
• Synergy Clinical Research Center — National City, California, United States
• Neuropsychiatric Research Center of Orange County — Orange, California, United States
• Pacific Clinical Research Medical Group — Orange, California, United States
• Elite Clinical Trials, Incorporated — Wildomar, California, United States
• Children's Hospital Colorado — Aurora, Colorado, United States
• Amedica Research Institute, Incorporated — Hialeah, Florida, United States
• Clinical Neuroscience Solutions, Inc. — Orlando, Florida, United States
• Kolin Research Group — Winter Park, Florida, United States
• Atlanta Center for Medical Research — Atlanta, Georgia, United States
• Institute for Behavioral Medicine, LLC — Smyrna, Georgia, United States
• Psychiatric Associates — Overland Park, Kansas, United States
• Lake Charles Clinical Trials, — Lake Charles, Louisiana, United States
• Precise Research Centers — Flowood, Mississippi, United States
• St. Charles Psychiatric Associates - Midwest Research Group — Saint Charles, Missouri, United States
• Center for Psychiatry and Behavioral Medicine, Incorporated — Las Vegas, Nevada, United States
• North Star Medical Research, LLC — Middleburg Heights, Ohio, United States
• IPS Research Company — Oklahoma City, Oklahoma, United States
• Cutting Edge Research Group — Oklahoma City, Oklahoma, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.